B
Bellevue Group AG
Bellevue Group AG is an institution, managing $4.8B across 147 long positions as of Q3 2025 with 88% Healthcare concentration, 50% concentrated in top 10 holdings, and minimal technology exposure.
- Portfolio Value
- $4.8B
- Positions
- 147
- Top Holding
- IONS at 8.51%
- Last Reported
- Q3 2025
Top Holdings
Largest long holdings in Bellevue Group AG's portfolio (50.1% of total portfolio)
GthenH
| Holding | Sector | Position | Weight | Traded | Ownership |
|---|---|---|---|---|---|
Biotechnology Healthcare | $408.5M | 8.51% | -$105.2M Sold | 3.92% 6.2M shares | |
Unknown Unknown | $402.9M | 8.39% | -$18.2M Sold | — 546.3K shares | |
Biotechnology Healthcare | $260.3M | 5.42% | +$46.4M Bought | 2.98% 5.6M shares | |
Drug Manufacturers - Specialty & Generic Healthcare | $247.5M | 5.15% | -$8.0M Sold | 1.78% 1.8M shares | |
Biotechnology Healthcare | $203.6M | 4.24% | -$104.8M Sold | 0.34% 446.5K shares | |
Biotechnology Healthcare | $198.1M | 4.13% | +$25.1M Bought | 0.20% 505.8K shares | |
Medical - Devices Healthcare | $198.0M | 4.12% | -$11.4M Sold | 0.08% 1.5M shares | |
Medical - Devices Healthcare | $166.8M | 3.47% | -$31.0M Sold | 0.12% 451.1K shares | |
Medical - Devices Healthcare | $162.1M | 3.38% | -$10.3M Sold | 0.11% 1.7M shares | |
Medical - Instruments & Supplies Healthcare | $155.9M | 3.25% | -$13.5M Sold | 0.10% 348.6K shares |
Changes
Portfolio activity, position movements, and quarter-over-quarter changes in Bellevue Group AG's latest filing
GthenC
Market Value
Q/Q Change
Net Flows % of MV
Turnover Ratio
New Purchases
Added To
Sold Out Of
Reduced Holdings
Increased Positions
| Position | Shares Δ |
|---|---|
New | |
New | |
New | |
New | |
New |
Decreased Positions
| Position | Shares Δ |
|---|---|
Sold | |
Sold | |
Sold | |
Sold | |
Sold |
Analytics
Portfolio insights and performance metrics for Bellevue Group AG
GthenA